tradingkey.logo

Elanco Animal Health Inc

ELAN
查看詳細走勢圖
25.200USD
+0.910+3.74%
收盤 02/06, 16:00美東報價延遲15分鐘
12.52B總市值
348.40本益比TTM

Elanco Animal Health Inc

25.200
+0.910+3.74%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.74%

5天

+4.65%

1月

+10.33%

6月

+52.91%

今年開始到現在

+11.36%

1年

+118.75%

查看詳細走勢圖

TradingKey Elanco Animal Health Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Elanco Animal Health Inc當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在藥品行業排名22/159位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為26.46。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Elanco Animal Health Inc評分

相關信息

行業排名
22 / 159
全市場排名
67 / 4521
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Elanco Animal Health Inc亮點

亮點風險
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值348.40,處於3年歷史高位
機構加倉
最新機構持股577.24M股,環比增加0.01%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉6.39K股
活躍度增加
近期活躍度增加,過去20天平均換手率1.06

分析師目標

基於 16 分析師
買入
評級
26.462
目標均價
+8.45%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Elanco Animal Health Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Elanco Animal Health Inc簡介

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
公司代碼ELAN
公司Elanco Animal Health Inc
CEOSimmons (Jeffrey N)
網址https://www.elanco.com/
KeyAI